NCT01013532 PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage Status UNKNOWN Phase PHASE4
NCT00983580 Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00959621 Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion Status COMPLETED Phase PHASE3
NCT00946907 Benign Acute Pericarditis: Brief Versus Longer Treatment Using Aspirin Status TERMINATED Phase PHASE4
NCT00942617 Measurement of Platelet Dense Granule Release in Healthy Volunteers Status WITHDRAWN Phase NA
NCT00940784 Clopidogrel and Aspirin for the Treatment of Polycythemia Vera Status WITHDRAWN Phase PHASE2
NCT00898950 Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes Status COMPLETED Phase NA
NCT00898222 Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects Status COMPLETED Phase NA
NCT00891670 Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism Status UNKNOWN Phase PHASE3
NCT00886574 Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events Status UNKNOWN Phase PHASE4
NCT00882388 The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers Status COMPLETED Phase PHASE4
NCT00847860 Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions Status COMPLETED Phase PHASE4
NCT00833833 MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT00827411 Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy Status COMPLETED Phase PHASE4
NCT00823212 The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions Status COMPLETED Phase PHASE3